Simplify Logo

Full-Time

Head of People

Posted on 6/21/2024

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Compensation Overview

$150k - $275kAnnually

+ Equity

Expert

Sacramento, CA, USA + 1 more

Category
Human Resources
People & HR
Requirements
  • 10+ years of progressive HR management experience
  • Experience in a Life Science company is preferred
  • Prior experience as an HR partner for a manufacturing (non-exempt) workforce preferred
  • Fluency in coaching senior leadership on complex people issues
  • Strong knowledge of HR compliance, legislation, and best practices
  • Experience in a rapid growth or start-up environment preferred, building and sustaining a positive culture
  • Experience designing and implementing exceptional HR frameworks (e.g., de-centralized organizational structure)
  • Genuine curiosity, open-mindedness and a strong desire for continuous learning
  • Sense of humor, patience and passion for people
  • Bachelor's degree in HR, Business Administration, Psychology, or related field (Master's preferred)
Responsibilities
  • Develop and implement innovative HR strategies aligned with organizational goals
  • Drive organizational effectiveness and employee engagement initiatives
  • Partner with the team to design and lead implementation of cutting-edge HR programs
  • Provide strategic consultation to enhance employee performance and engagement
  • Manage employee relations with sensitivity and compliance
  • Collaborate with internal teams for a seamless employee experience
  • Offer data-driven recommendations for performance improvement
  • Partner with the team to define talent planning processes
  • Establish policies for training, onboarding, career development, and termination
  • Stay abreast of HR trends, regulatory changes, and new technologies
  • Provide executive coaching to the leadership team

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to significantly impact healthcare by advancing cell therapy treatments for conditions that currently have limited options.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

8%

1 year growth

14%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.
INACTIVE